GSK GSK plc
Stable Earnings Power
B 73.5 / 100 composite

AlphaQuality composite grade, weighted for stable earnings power businesses.

Profitability

Weight: 20%
B+ 76
  • 5yr Avg ROIC 14.1%
  • Operating Margin Trend +0.66 pp/yr

Capital Efficiency

Weight: 15%
A- 85
  • 5yr Avg ROE 49.1%
  • 5yr Share-Count CAGR 0.4%

Growth Quality

Weight: 15%
C 56
  • 5yr Revenue CAGR 6.1%
  • 5yr EPS CAGR -0.6%
  • Revenue-Growth Years (5) 5/5

Cash Generation

Weight: 15%
A 93
  • 5yr FCF Margin 18.9%
  • 5yr FCF/NI Conversion 1.07x

Balance Sheet

Weight: 20%
B 73
  • Net Debt / EBITDA 1.37x
  • Interest Coverage (EBIT/Int) 11.77x
  • Altman Z-Score 2.09

Stability

Weight: 15%
C+ 57
  • EPS Volatility (σ/μ) 0.72
  • Negative-Revenue Years (5) 0/5
  • Piotroski F-Score 8

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

3 of 3 gurus held; 2 added; 1 trimmed.

Holders
3 +1
Avg Δ position
+50.5%
New buys
0
Full exits
0
As of Q2 2026